Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase InhibitorsBioSeeker Group ABMay 1, 2012 4773 Pages - SKU: BIOS3874005 |
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
Oropharyngeal Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Oropharyngeal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oropharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer,
|
read more...
|
$2,000.00
|
|
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic
|
read more...
|
$2,000.00
|
|
US Personalized Cancer Genome Sequencing Marketrncos
5/1/2013 | published by: RNCOS
The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. “ US Personalized Cancer Genome Sequencing Market ” takes into account the Whole-Genome Sequencing services, which is one of the most
|
read more...
|
$1,200.00
|
|
Soft Tissue Sarcoma – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Soft Tissue Sarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Soft Tissue Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic
|
read more...
|
$2,000.00
|
|
Lymphoma Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for lymphoma treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
read more...
|
$2,000.00
|
|
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on
|
read more...
|
$2,000.00
|
|
Cancer Pain Global Clinical Trials Review, H1, 2013
4/30/2013 | published by: GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013 provides data on the Cancer Pain clinical trial scenario. This report provides elemental information and data
|
read more...
|
$2,500.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Oncology/Hematology Reports